SlideShare a Scribd company logo
Dynamic Optimization of a Linear-Quadratic Model with Incomplete Repair and Volume-Dependent Sensitivity and Repopulation Lawrence M. Wein Jonathan E. Cohen
Abstract Purpose :   The linear-quadratic model typically assumes that tumor sensitivity and repopulation are constant over the time course of radiotherapy.  However, evidence suggests that the  growth fraction increases  and the  cell loss factor decreases  as the tumor shrinks. We investigate whether this  evolution in tumor geometry , as well as the  irregular time intervals between fractions  in hyperfractionation schemes, can be exploited by fractionation schedules that employ  time-varying fraction sizes .
Methods:   We construct a mathematical model of a spherical tumor with a  hypoxic core and a viable rim , and embed this model into the traditional linear-quadratic model by assuming instantaneous reoxygenation.  Dynamic programming is used to numerically compute the fractionation regimen that  maximizes the tumor control probability  (TCP) subject to constraints on the biologically effective dose of the early and late tissues.
Results:   In a numerical example that employs 10 fractions per week, optimally varying the fraction sizes increases the  TCP from 0.7 to 0.966 , and the optimal regimen incorporates  large Friday afternoon doses  that are escalated throughout the course of treatment, and  larger afternoon doses than morning doses. Conclusions:     Numerical results suggest that a significant increase in tumor cure can be achieved by  allowing the fraction sizes to vary  throughout the course of treatment.    Several strategies deserve further investigation: using  larger fractions before overnight and weekend breaks , and escalating the dose (particularly on Friday afternoons) throughout the course of treatment.
Linear Quadratic Model: Survival Curves plot the fraction of cells surviving radiation against the dose. This survival curve is best described by a linear quadratic model with the following formula:  S = e -( α D +   β D2) The  α  and  β  terms in this equation and the  α  /  β   ratio are used to describe survival curve characteristics and to classify cellular response to radiation.
Tumor Control Probability Success or failure in controlling a tumor depends on  killing the last surviving clonogen . Therefore, in terms of attempting permanent tumor control,  if even one clonogen survives, the whole dose is wasted . A plot of  control versus dose  for a single tumor is therefore one of  0% response up to a certain dose  and then an  immediate increase to 100%  response at the death of the last clonogen. However, the shape of the tumor control probability   (TCP) curve for a series of patients ,  is different because cell killing is a random process.   For example, if  on an average 4 cars will cross  a particular speed breaker in a road  in one minute , what is the  probability that no car will cross  the point in a particular minute, or the  probability that 1 car will cross  the point. The answer to this question is given by the  Poisson Distribution .
Similarly, if a certain dose were to reduce the cell survival to an   average of one clonogen per tumor ,  there would be, on average, among   the series  37% with no survivors ,  37% with one surviving clonogen,  18.4% with two surviving clonogens,  6.1% with three surviving clonogens, and  1.5% with four or more surviving clonogens.  This 37% of tumors with no surviving clonogen will be declared cured, and the tumor control probability  (TCP) is 37%. Poisson statistics correlate probability of tumor control with cell survival rate by the following formula:    P=e -x where  x is the average number of surviving clonogens  per tumor, which in turn is the product of S.F. (fraction of cells surviving) and M (initial cell number).
This study was stimulated by  two perceived gaps  in the LQ literature.  The first gap is that the  use of temporal optimization  to exploit the irregular time intervals present in traditional non-accelerated protocols has yet to be studied.  The second gap is the failure of the LQ model to capture the  dynamics of reoxygenation  and repopulation throughout the course of treatment. Evidence suggests that the  evolution of tumor geometry  during radiation treatment and its  impact on radiosensitivity and repopulation  can be exploited by time-varying fractionation regimens to further improve the therapeutic ratio. As a tumor shrinks during the course of therapy, diffusion-limited hypoxia decreases and necrotic regions become smaller and may eventually vanish.
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Tumor geometry . We consider a spherical tumor that consists of a  hypoxic core  and a viable rim .  The tumor's size is defined by its radius  R , which changes over time as a result of  radiation killing, necrotic loss and repopulation.  R If the current radius  R  is less than  ro  , (Oxygen Diffusion Distance)   then the tumor contains no hypoxic core.  R < ro R > ro If  R  >  ro   then the viable rim consists of the outer shell of thickness  ro  and the hypoxic core is the inner sphere of radius R -  ro.
Location-dependent sensitivity and repopulation. In our model, a cell's sensitivity  ( α  and  β ) and its net repopulation rate ( γ ) depends upon its  radial distance,  r ,  from the center of the tumor, and on the current tumor radius,  R. All three quantities, which will be defined by  α (r, R),  β (r, R)  and  γ (r, R),  take on a fixed well-oxygenated level (denoted by  α 0,  β 0,  γ 0 ) at the tumor surface (i.e.,  r  =  R)  and decrease linearly as  r  decreases. α 0,  β 0,  γ 0 (r=R) 0,0,0 (r=R-ro)
A tumor's overall sensitivity and repopulation rate. If  f( α ,  β ,  γ )  is the joint probability density function of the three parameters for the various cells in a tumor of fixed size ,then the expected surviving fraction of cells after a dose of size  d  given over the infinitesimal interval of time The  effective values of  α ,  β , and  γ   are given by,  respectively.
The equivalent ODE . Suppose an arbitrary dose rate  dt  is applied over the time interval [0, T]. The surviving fraction of cells under the traditional (i.e.,  constant  α   and  β   and  γ  = 0 ) LQ model with incomplete repair (with  repair rate  μ )  is α D  β D 2 To obtain an analogous result for volume-dependent sensitivity  ( α t  ,  β t  )  and repopulation  ( γ t   ),  we use the ODE model. Because the sensitivity and repopulation functions are expressed in terms of the radius, we need to express the differential equation in terms of the radius, not the number of cells.
Problem formulation: The optimization problem is to choose a radiation schedule that  maximizes the tumor control probability (TCP),  subject to a  constraint on the biologically effective dose (BED) of the early and late tissues .  Mathematically, the problem is to choose  T  and  {dt  > 0, 0 < t <  T} to maximize Subject to constraints
Results: We restrict our numerical study to fractionation schemes that have 10 fractions per week. Time t = 0 corresponds to the first fraction given on Monday morning, there are  two fractions per day that are separated by eight hours  (each fraction's duration is one minute), and there is  no treatment on the weekends.  First, the initial tumor radius  Ro  is set equal to 0.5 cm , which corresponds to a typical tumor at the time of presentation. We set the  viable rim radius  ro  equal to 0.05 cm , which is about three times larger than the oxygen diffusion limit in tumor tissue in order to reflect the fact that a tumor of this size would be vascularized. This value leads to 27.1% of the tumor being viable initially. The  loss rate for necrotic debris  is taken to be
To assess the efficacy of the optimal solution, we compare it to the best static (i.e., fraction sizes do not vary over time) scheme, the  hyperfractionation  (HF) (70 fractions x 1.15 Gy) regimen and  whose TCP is 0.7. The optimal solution to is displayed in Figure.  This scheme administers a total of  66.81 Gy in six weeks , and achieves a  TCP of 0.966 , which is a significant improvement over HF's TCP of 0.7. The resulting BED administered to the early and late tissues is 4.59 Gy and 98.5 Gy, respectively. Hence, the early constraint is binding under the optimal scheme but the late constraint has a slack of 13 Gy.
The optimal solution in Figure possesses several interesting features.  The most pronounced effect is the  large doses on Friday afternoons .  These large fractions are primarily used to  compensate for the weekend  breaks. However, a secondary factor could be that  tumors are also smaller on Friday afternoon  than at other times of the week, and  smaller tumors are more sensitive and may attract larger fractions .  There is also a significant  am-pm effect :  60.0%  of the total dose on Monday through Thursdays is administered in the  afternoons . These large afternoon fractions offset the  repopulation during the 16-hour gap  until the next morning's fraction.  A third feature of Figure is the  intensification of the Friday afternoon doses  throughout the course of treatment.
Discussion: The foundation of the rationale for current fractionation schemes is the exploitation of the differences in radiation sensitivity and repopulation between the tumor and the normal (primarily late) tissue.  Recent results show how the  difference in repair rates can also be exploited by temporally optimizing the dose rate  in accelerated protocols.  The results in the present paper complement these ideas by suggesting that the therapeutic ratio can be further improved by  exploiting two other factors :  Irregular time intervals  between doses caused by overnight and  weekend breaks, and  the  changing radiosensitivity  and repopulation rate of the tumor  caused by reoxygenation.
The  weekend break  was the most pronounced effect in our numerical example, causing  Friday afternoon doses to be about 3.5 times larger  than the other doses.  The  overnight effect  was also significant, with  afternoon doses accounting for 60.0%  of the total dose administered on Mondays through Thursdays.  The tumor  increased its radiosensitivity and repopulation rates throughout the course of treatment , leading to 16.8% larger Friday afternoon doses in the latter three weeks of treatment than in the first three weeks of treatment. The optimal fractionation scheme compensates for irregular time intervals between doses by administering  larger doses before longer breaks  and  shorter doses before shorter breaks .
The optimal radiation policy exploits the reoxygenation process by taking into account the fact that  as the tumor gets smaller , the  tumor's sensitivity increases. Hence, giving  large doses at the beginning of therapy is wasteful , since some of this dose can kill more cells if it is deferred until the tumor is smaller.  Moreover,  as the tumor shrinks, the growth fraction increases and the cell loss factor decreases, and consequently the repopulation rate increases . This provides an additional incentive to increase the dose rate (thereby reducing the length of treatment) when the tumor is smaller. In summary, an optimal radiation policy attempts to exercise patience when faced with a large tumor: it  slowly and methodically chips away at the outer surface  of the tumor, until the hypoxic core is sufficiently small, at which time the dose rate is increased until the end of treatment.
Clinical Relevance: Dose intensification throughout the course of treatment can also be seen in  concomitant boost (CB) therapy , where  daily 1.8 Gy fractions  are given for six weeks to the standard  large field,   plus an  additional 1.5 Gy fraction  is delivered to a reduced field  on a daily basis for the  last 10-12 days  of treatment. The boost appears to be more efficacious when administered  late in treatment rather than early, which is  consistent with our results .
Future Directions: Our results suggest that there is  untapped potential for the use of dynamic fractionation schemes  that incorporate the  overnight effect, the weekend effect and the dose escalation effect .  Our hope is that these types of models and analyses will provide a systematic way of generating and refining approaches to improve the therapeutic ratio of radiotherapy by  temporal optimization of dose schedules.

More Related Content

What's hot

To use or not to use the LQ model at “high” radiation doses
To use or not to use the LQ model at “high” radiation doses To use or not to use the LQ model at “high” radiation doses
To use or not to use the LQ model at “high” radiation doses
Santam Chakraborty
 
Radiation Oncology Slides 2003 1203
Radiation Oncology Slides 2003 1203Radiation Oncology Slides 2003 1203
Radiation Oncology Slides 2003 1203
Ahamed Badusha
 
Physical Models For Time Dose & Fractionation
Physical Models For Time Dose & FractionationPhysical Models For Time Dose & Fractionation
Physical Models For Time Dose & Fractionation
Isha Jaiswal
 
4 rs of radiobiology
4 rs of radiobiology4 rs of radiobiology
4 rs of radiobiology
Asmita Rayamajhi
 
2012-michael joiner-hypofractionation
2012-michael joiner-hypofractionation2012-michael joiner-hypofractionation
2012-michael joiner-hypofractionationfondas vakalis
 
Linear quadratic model ppt
Linear quadratic model pptLinear quadratic model ppt
Linear quadratic model ppt
Nilesh Kucha
 
cell survival curve
cell survival curvecell survival curve
cell survival curve
Dr Vijay Raturi
 
HYPOFRACTIONATION IN RADIOTHERAPY
HYPOFRACTIONATION IN RADIOTHERAPYHYPOFRACTIONATION IN RADIOTHERAPY
HYPOFRACTIONATION IN RADIOTHERAPY
Rejil Rajan
 
Time, dose and fractionation
Time, dose and fractionationTime, dose and fractionation
Time, dose and fractionation
Dr. Ankita Pandey
 
Cell survival curve
Cell survival curve Cell survival curve
Cell survival curve
Isha Jaiswal
 
Radiobiology for radiotherapy residents
Radiobiology for radiotherapy residentsRadiobiology for radiotherapy residents
Radiobiology for radiotherapy residents
Dr.Saadvik Raghuram
 
Principles of chemoradiations
Principles of chemoradiationsPrinciples of chemoradiations
Principles of chemoradiations
Dr. Abani Kanta Nanda
 
Novel rt in sarc2017
Novel rt in sarc2017Novel rt in sarc2017
Novel rt in sarc2017
Mohammad Gouran savadkoohi
 
RE-IRRADIATION IN HEAD AND NECK CANCER
RE-IRRADIATION IN HEAD AND NECK CANCERRE-IRRADIATION IN HEAD AND NECK CANCER
RE-IRRADIATION IN HEAD AND NECK CANCER
MUNEER khalam
 
Radiation therapy in head and neck cancer
Radiation therapy in head and neck cancerRadiation therapy in head and neck cancer
Radiation therapy in head and neck cancer
SREENIVAS KAMATH
 
TIME DOSE & FRACTIONATION
TIME DOSE & FRACTIONATIONTIME DOSE & FRACTIONATION
TIME DOSE & FRACTIONATION
Isha Jaiswal
 
Principles of Radiotherapy in Head & Neck Surgery and Recent Advances A by Dr...
Principles of Radiotherapy in Head & Neck Surgery and Recent Advances A by Dr...Principles of Radiotherapy in Head & Neck Surgery and Recent Advances A by Dr...
Principles of Radiotherapy in Head & Neck Surgery and Recent Advances A by Dr...
Aditya Tiwari
 
RADIATION CARCINOGENESIS
RADIATION CARCINOGENESISRADIATION CARCINOGENESIS
RADIATION CARCINOGENESIS
Isha Jaiswal
 
Tissue radiosensitivity
Tissue radiosensitivityTissue radiosensitivity
Tissue radiosensitivityDeepaGautam
 

What's hot (20)

To use or not to use the LQ model at “high” radiation doses
To use or not to use the LQ model at “high” radiation doses To use or not to use the LQ model at “high” radiation doses
To use or not to use the LQ model at “high” radiation doses
 
Radiation Oncology Slides 2003 1203
Radiation Oncology Slides 2003 1203Radiation Oncology Slides 2003 1203
Radiation Oncology Slides 2003 1203
 
Physical Models For Time Dose & Fractionation
Physical Models For Time Dose & FractionationPhysical Models For Time Dose & Fractionation
Physical Models For Time Dose & Fractionation
 
Therapeutic Ratio
Therapeutic RatioTherapeutic Ratio
Therapeutic Ratio
 
4 rs of radiobiology
4 rs of radiobiology4 rs of radiobiology
4 rs of radiobiology
 
2012-michael joiner-hypofractionation
2012-michael joiner-hypofractionation2012-michael joiner-hypofractionation
2012-michael joiner-hypofractionation
 
Linear quadratic model ppt
Linear quadratic model pptLinear quadratic model ppt
Linear quadratic model ppt
 
cell survival curve
cell survival curvecell survival curve
cell survival curve
 
HYPOFRACTIONATION IN RADIOTHERAPY
HYPOFRACTIONATION IN RADIOTHERAPYHYPOFRACTIONATION IN RADIOTHERAPY
HYPOFRACTIONATION IN RADIOTHERAPY
 
Time, dose and fractionation
Time, dose and fractionationTime, dose and fractionation
Time, dose and fractionation
 
Cell survival curve
Cell survival curve Cell survival curve
Cell survival curve
 
Radiobiology for radiotherapy residents
Radiobiology for radiotherapy residentsRadiobiology for radiotherapy residents
Radiobiology for radiotherapy residents
 
Principles of chemoradiations
Principles of chemoradiationsPrinciples of chemoradiations
Principles of chemoradiations
 
Novel rt in sarc2017
Novel rt in sarc2017Novel rt in sarc2017
Novel rt in sarc2017
 
RE-IRRADIATION IN HEAD AND NECK CANCER
RE-IRRADIATION IN HEAD AND NECK CANCERRE-IRRADIATION IN HEAD AND NECK CANCER
RE-IRRADIATION IN HEAD AND NECK CANCER
 
Radiation therapy in head and neck cancer
Radiation therapy in head and neck cancerRadiation therapy in head and neck cancer
Radiation therapy in head and neck cancer
 
TIME DOSE & FRACTIONATION
TIME DOSE & FRACTIONATIONTIME DOSE & FRACTIONATION
TIME DOSE & FRACTIONATION
 
Principles of Radiotherapy in Head & Neck Surgery and Recent Advances A by Dr...
Principles of Radiotherapy in Head & Neck Surgery and Recent Advances A by Dr...Principles of Radiotherapy in Head & Neck Surgery and Recent Advances A by Dr...
Principles of Radiotherapy in Head & Neck Surgery and Recent Advances A by Dr...
 
RADIATION CARCINOGENESIS
RADIATION CARCINOGENESISRADIATION CARCINOGENESIS
RADIATION CARCINOGENESIS
 
Tissue radiosensitivity
Tissue radiosensitivityTissue radiosensitivity
Tissue radiosensitivity
 

Viewers also liked

presentation_adverts
presentation_advertspresentation_adverts
presentation_adverts
jordi
 
Fotos im Internet präsentieren
Fotos im Internet präsentierenFotos im Internet präsentieren
Fotos im Internet präsentieren
Ivan Blatter
 
Kcic bootcamp webinar_aug_2011
Kcic bootcamp webinar_aug_2011Kcic bootcamp webinar_aug_2011
Kcic bootcamp webinar_aug_2011Hack the Hood
 
Hack the hood engage local
Hack the hood engage localHack the hood engage local
Hack the hood engage local
Hack the Hood
 
WCM SharePoint 2013 #spsuk nov2013
WCM SharePoint 2013 #spsuk nov2013WCM SharePoint 2013 #spsuk nov2013
WCM SharePoint 2013 #spsuk nov2013
Marwan Tarek
 
Case Study: Knight News Challenge
Case Study: Knight News ChallengeCase Study: Knight News Challenge
Case Study: Knight News Challenge
Hack the Hood
 
Qwerly GeeknRolla Presentation
Qwerly GeeknRolla PresentationQwerly GeeknRolla Presentation
Qwerly GeeknRolla Presentation
Max Niederhofer
 
Presentation
PresentationPresentation
Presentation
jordi
 
Introduction to Search Engine Optimisation
Introduction to Search Engine OptimisationIntroduction to Search Engine Optimisation
Introduction to Search Engine Optimisation
E-Web Marketing
 
06 - Proposition d’Adoption de la Stratégie de Spécialisation Intelligente en...
06 - Proposition d’Adoption de la Stratégie de Spécialisation Intelligente en...06 - Proposition d’Adoption de la Stratégie de Spécialisation Intelligente en...
06 - Proposition d’Adoption de la Stratégie de Spécialisation Intelligente en...
Mohamed Larbi BEN YOUNES
 
Design Patterns on Social Navigation
Design Patterns on Social NavigationDesign Patterns on Social Navigation
Design Patterns on Social NavigationRuby Kuo
 
What Is Social Media
What Is Social MediaWhat Is Social Media
What Is Social MediaThomas Martin
 
An incident with duck vanya and planetcho
An incident with duck vanya and planetchoAn incident with duck vanya and planetcho
An incident with duck vanya and planetchoRositsa Dimova
 
Deforestation 2
Deforestation 2Deforestation 2
Deforestation 2
Rositsa Dimova
 

Viewers also liked (20)

presentation_adverts
presentation_advertspresentation_adverts
presentation_adverts
 
Fotos im Internet präsentieren
Fotos im Internet präsentierenFotos im Internet präsentieren
Fotos im Internet präsentieren
 
Eco palsen
Eco palsenEco palsen
Eco palsen
 
Eco palsbg
Eco palsbgEco palsbg
Eco palsbg
 
Edna sedmica v italia
Edna sedmica v italiaEdna sedmica v italia
Edna sedmica v italia
 
TIC e EAD
TIC e EADTIC e EAD
TIC e EAD
 
Kcic bootcamp webinar_aug_2011
Kcic bootcamp webinar_aug_2011Kcic bootcamp webinar_aug_2011
Kcic bootcamp webinar_aug_2011
 
Hack the hood engage local
Hack the hood engage localHack the hood engage local
Hack the hood engage local
 
WCM SharePoint 2013 #spsuk nov2013
WCM SharePoint 2013 #spsuk nov2013WCM SharePoint 2013 #spsuk nov2013
WCM SharePoint 2013 #spsuk nov2013
 
Case Study: Knight News Challenge
Case Study: Knight News ChallengeCase Study: Knight News Challenge
Case Study: Knight News Challenge
 
Qwerly GeeknRolla Presentation
Qwerly GeeknRolla PresentationQwerly GeeknRolla Presentation
Qwerly GeeknRolla Presentation
 
Buku rekod
Buku rekodBuku rekod
Buku rekod
 
Presentation
PresentationPresentation
Presentation
 
Introduction to Search Engine Optimisation
Introduction to Search Engine OptimisationIntroduction to Search Engine Optimisation
Introduction to Search Engine Optimisation
 
06 - Proposition d’Adoption de la Stratégie de Spécialisation Intelligente en...
06 - Proposition d’Adoption de la Stratégie de Spécialisation Intelligente en...06 - Proposition d’Adoption de la Stratégie de Spécialisation Intelligente en...
06 - Proposition d’Adoption de la Stratégie de Spécialisation Intelligente en...
 
Design Patterns on Social Navigation
Design Patterns on Social NavigationDesign Patterns on Social Navigation
Design Patterns on Social Navigation
 
What Is Social Media
What Is Social MediaWhat Is Social Media
What Is Social Media
 
An incident with duck vanya and planetcho
An incident with duck vanya and planetchoAn incident with duck vanya and planetcho
An incident with duck vanya and planetcho
 
Deforestation 2
Deforestation 2Deforestation 2
Deforestation 2
 
Andrea 5a
Andrea 5aAndrea 5a
Andrea 5a
 

Similar to Dynamic Fractionation in Radiotherapy

Dose Evaluation in the Movement Couch of the Total Body Irradiation Technique...
Dose Evaluation in the Movement Couch of the Total Body Irradiation Technique...Dose Evaluation in the Movement Couch of the Total Body Irradiation Technique...
Dose Evaluation in the Movement Couch of the Total Body Irradiation Technique...
iosrjce
 
PATHway to Decoding the Impact of Cancer Immunotherapy: Latest Advances in Bi...
PATHway to Decoding the Impact of Cancer Immunotherapy: Latest Advances in Bi...PATHway to Decoding the Impact of Cancer Immunotherapy: Latest Advances in Bi...
PATHway to Decoding the Impact of Cancer Immunotherapy: Latest Advances in Bi...
PVI, PeerView Institute for Medical Education
 
Topic of the month.... The role of gamma knife in the management of benign br...
Topic of the month.... The role of gamma knife in the management of benign br...Topic of the month.... The role of gamma knife in the management of benign br...
Topic of the month.... The role of gamma knife in the management of benign br...
Professor Yasser Metwally
 
Time , Dose & Fractionationrevised
Time , Dose & FractionationrevisedTime , Dose & Fractionationrevised
Time , Dose & FractionationrevisedPGIMER, AIIMS
 
Sacral chordoma
Sacral chordomaSacral chordoma
Sacral chordoma
Nora Essam
 
Parsing the Practicalities of Pathologic Response Assessment After Neoadjuvan...
Parsing the Practicalities of Pathologic Response Assessment After Neoadjuvan...Parsing the Practicalities of Pathologic Response Assessment After Neoadjuvan...
Parsing the Practicalities of Pathologic Response Assessment After Neoadjuvan...
PVI, PeerView Institute for Medical Education
 
ca oropharynx
ca oropharynxca oropharynx
ca oropharynx
vrinda singla
 
How to Integrate Perioperative Immunotherapy Into Multimodal Treatment Plans ...
How to Integrate Perioperative Immunotherapy Into Multimodal Treatment Plans ...How to Integrate Perioperative Immunotherapy Into Multimodal Treatment Plans ...
How to Integrate Perioperative Immunotherapy Into Multimodal Treatment Plans ...
PVI, PeerView Institute for Medical Education
 
Realizing the Promise of Perioperative Immunotherapy in Resectable NSCLC: How...
Realizing the Promise of Perioperative Immunotherapy in Resectable NSCLC: How...Realizing the Promise of Perioperative Immunotherapy in Resectable NSCLC: How...
Realizing the Promise of Perioperative Immunotherapy in Resectable NSCLC: How...
PVI, PeerView Institute for Medical Education
 
4 r's of radiobiology and dose rate effects
4 r's of radiobiology and dose rate effects4 r's of radiobiology and dose rate effects
4 r's of radiobiology and dose rate effects
Dr.laxman Pandey
 
Ecmtb2014 vascular patterning
Ecmtb2014 vascular patterningEcmtb2014 vascular patterning
Ecmtb2014 vascular patterning
University of Oxford, Moffitt Cancer Center
 
Whole body retention of I-131 at 24hr vs 48hr as a predictor of maximum tole...
Whole body retention of  I-131 at 24hr vs 48hr as a predictor of maximum tole...Whole body retention of  I-131 at 24hr vs 48hr as a predictor of maximum tole...
Whole body retention of I-131 at 24hr vs 48hr as a predictor of maximum tole...Michael
 
Cell survival curve ppt.
Cell survival curve ppt.Cell survival curve ppt.
Cell survival curve ppt.
Luri Borah
 
7. Radiobiology behind Dose Fractionation.ppt
7. Radiobiology behind Dose Fractionation.ppt7. Radiobiology behind Dose Fractionation.ppt
7. Radiobiology behind Dose Fractionation.ppt
Susana Branco
 
Radiation oncology
Radiation oncologyRadiation oncology
Radiation oncologyRad Tech
 
ISMRM 2001 Poster: Identifying Tumor Permeability Heterogeneity with MRI Cont...
ISMRM 2001 Poster: Identifying Tumor Permeability Heterogeneity with MRI Cont...ISMRM 2001 Poster: Identifying Tumor Permeability Heterogeneity with MRI Cont...
ISMRM 2001 Poster: Identifying Tumor Permeability Heterogeneity with MRI Cont...
Mike Aref
 
CELL SURVIVAL CURVE.pptx
CELL SURVIVAL CURVE.pptxCELL SURVIVAL CURVE.pptx
CELL SURVIVAL CURVE.pptx
masthan basha
 
Radiotherapy contouring guideline for non-hodgkin lymphoma
Radiotherapy contouring guideline for non-hodgkin lymphomaRadiotherapy contouring guideline for non-hodgkin lymphoma
Radiotherapy contouring guideline for non-hodgkin lymphoma
ketan kalariya
 
Concurrent Chemoradiotherapy-Principles.ppt
Concurrent Chemoradiotherapy-Principles.pptConcurrent Chemoradiotherapy-Principles.ppt
Concurrent Chemoradiotherapy-Principles.ppt
DR REJIL RAJAN
 

Similar to Dynamic Fractionation in Radiotherapy (20)

Dose Evaluation in the Movement Couch of the Total Body Irradiation Technique...
Dose Evaluation in the Movement Couch of the Total Body Irradiation Technique...Dose Evaluation in the Movement Couch of the Total Body Irradiation Technique...
Dose Evaluation in the Movement Couch of the Total Body Irradiation Technique...
 
PATHway to Decoding the Impact of Cancer Immunotherapy: Latest Advances in Bi...
PATHway to Decoding the Impact of Cancer Immunotherapy: Latest Advances in Bi...PATHway to Decoding the Impact of Cancer Immunotherapy: Latest Advances in Bi...
PATHway to Decoding the Impact of Cancer Immunotherapy: Latest Advances in Bi...
 
Topic of the month.... The role of gamma knife in the management of benign br...
Topic of the month.... The role of gamma knife in the management of benign br...Topic of the month.... The role of gamma knife in the management of benign br...
Topic of the month.... The role of gamma knife in the management of benign br...
 
Time , Dose & Fractionationrevised
Time , Dose & FractionationrevisedTime , Dose & Fractionationrevised
Time , Dose & Fractionationrevised
 
Sacral chordoma
Sacral chordomaSacral chordoma
Sacral chordoma
 
Parsing the Practicalities of Pathologic Response Assessment After Neoadjuvan...
Parsing the Practicalities of Pathologic Response Assessment After Neoadjuvan...Parsing the Practicalities of Pathologic Response Assessment After Neoadjuvan...
Parsing the Practicalities of Pathologic Response Assessment After Neoadjuvan...
 
ca oropharynx
ca oropharynxca oropharynx
ca oropharynx
 
How to Integrate Perioperative Immunotherapy Into Multimodal Treatment Plans ...
How to Integrate Perioperative Immunotherapy Into Multimodal Treatment Plans ...How to Integrate Perioperative Immunotherapy Into Multimodal Treatment Plans ...
How to Integrate Perioperative Immunotherapy Into Multimodal Treatment Plans ...
 
Realizing the Promise of Perioperative Immunotherapy in Resectable NSCLC: How...
Realizing the Promise of Perioperative Immunotherapy in Resectable NSCLC: How...Realizing the Promise of Perioperative Immunotherapy in Resectable NSCLC: How...
Realizing the Promise of Perioperative Immunotherapy in Resectable NSCLC: How...
 
4 r's of radiobiology and dose rate effects
4 r's of radiobiology and dose rate effects4 r's of radiobiology and dose rate effects
4 r's of radiobiology and dose rate effects
 
Ecmtb2014 vascular patterning
Ecmtb2014 vascular patterningEcmtb2014 vascular patterning
Ecmtb2014 vascular patterning
 
Whole body retention of I-131 at 24hr vs 48hr as a predictor of maximum tole...
Whole body retention of  I-131 at 24hr vs 48hr as a predictor of maximum tole...Whole body retention of  I-131 at 24hr vs 48hr as a predictor of maximum tole...
Whole body retention of I-131 at 24hr vs 48hr as a predictor of maximum tole...
 
Cell survival curve ppt.
Cell survival curve ppt.Cell survival curve ppt.
Cell survival curve ppt.
 
7. Radiobiology behind Dose Fractionation.ppt
7. Radiobiology behind Dose Fractionation.ppt7. Radiobiology behind Dose Fractionation.ppt
7. Radiobiology behind Dose Fractionation.ppt
 
report
reportreport
report
 
Radiation oncology
Radiation oncologyRadiation oncology
Radiation oncology
 
ISMRM 2001 Poster: Identifying Tumor Permeability Heterogeneity with MRI Cont...
ISMRM 2001 Poster: Identifying Tumor Permeability Heterogeneity with MRI Cont...ISMRM 2001 Poster: Identifying Tumor Permeability Heterogeneity with MRI Cont...
ISMRM 2001 Poster: Identifying Tumor Permeability Heterogeneity with MRI Cont...
 
CELL SURVIVAL CURVE.pptx
CELL SURVIVAL CURVE.pptxCELL SURVIVAL CURVE.pptx
CELL SURVIVAL CURVE.pptx
 
Radiotherapy contouring guideline for non-hodgkin lymphoma
Radiotherapy contouring guideline for non-hodgkin lymphomaRadiotherapy contouring guideline for non-hodgkin lymphoma
Radiotherapy contouring guideline for non-hodgkin lymphoma
 
Concurrent Chemoradiotherapy-Principles.ppt
Concurrent Chemoradiotherapy-Principles.pptConcurrent Chemoradiotherapy-Principles.ppt
Concurrent Chemoradiotherapy-Principles.ppt
 

Recently uploaded

Scope Of Macroeconomics introduction and basic theories
Scope Of Macroeconomics introduction and basic theoriesScope Of Macroeconomics introduction and basic theories
Scope Of Macroeconomics introduction and basic theories
nomankalyar153
 
how to sell pi coins on Bitmart crypto exchange
how to sell pi coins on Bitmart crypto exchangehow to sell pi coins on Bitmart crypto exchange
how to sell pi coins on Bitmart crypto exchange
DOT TECH
 
What price will pi network be listed on exchanges
What price will pi network be listed on exchangesWhat price will pi network be listed on exchanges
What price will pi network be listed on exchanges
DOT TECH
 
how to sell pi coins in South Korea profitably.
how to sell pi coins in South Korea profitably.how to sell pi coins in South Korea profitably.
how to sell pi coins in South Korea profitably.
DOT TECH
 
what is the best method to sell pi coins in 2024
what is the best method to sell pi coins in 2024what is the best method to sell pi coins in 2024
what is the best method to sell pi coins in 2024
DOT TECH
 
Empowering the Unbanked: The Vital Role of NBFCs in Promoting Financial Inclu...
Empowering the Unbanked: The Vital Role of NBFCs in Promoting Financial Inclu...Empowering the Unbanked: The Vital Role of NBFCs in Promoting Financial Inclu...
Empowering the Unbanked: The Vital Role of NBFCs in Promoting Financial Inclu...
Vighnesh Shashtri
 
where can I find a legit pi merchant online
where can I find a legit pi merchant onlinewhere can I find a legit pi merchant online
where can I find a legit pi merchant online
DOT TECH
 
一比一原版BCU毕业证伯明翰城市大学毕业证成绩单如何办理
一比一原版BCU毕业证伯明翰城市大学毕业证成绩单如何办理一比一原版BCU毕业证伯明翰城市大学毕业证成绩单如何办理
一比一原版BCU毕业证伯明翰城市大学毕业证成绩单如何办理
ydubwyt
 
Which Crypto to Buy Today for Short-Term in May-June 2024.pdf
Which Crypto to Buy Today for Short-Term in May-June 2024.pdfWhich Crypto to Buy Today for Short-Term in May-June 2024.pdf
Which Crypto to Buy Today for Short-Term in May-June 2024.pdf
Kezex (KZX)
 
Poonawalla Fincorp and IndusInd Bank Introduce New Co-Branded Credit Card
Poonawalla Fincorp and IndusInd Bank Introduce New Co-Branded Credit CardPoonawalla Fincorp and IndusInd Bank Introduce New Co-Branded Credit Card
Poonawalla Fincorp and IndusInd Bank Introduce New Co-Branded Credit Card
nickysharmasucks
 
what is the future of Pi Network currency.
what is the future of Pi Network currency.what is the future of Pi Network currency.
what is the future of Pi Network currency.
DOT TECH
 
Introduction to Indian Financial System ()
Introduction to Indian Financial System ()Introduction to Indian Financial System ()
Introduction to Indian Financial System ()
Avanish Goel
 
Exploring Abhay Bhutada’s Views After Poonawalla Fincorp’s Collaboration With...
Exploring Abhay Bhutada’s Views After Poonawalla Fincorp’s Collaboration With...Exploring Abhay Bhutada’s Views After Poonawalla Fincorp’s Collaboration With...
Exploring Abhay Bhutada’s Views After Poonawalla Fincorp’s Collaboration With...
beulahfernandes8
 
how can I sell/buy bulk pi coins securely
how can I sell/buy bulk pi coins securelyhow can I sell/buy bulk pi coins securely
how can I sell/buy bulk pi coins securely
DOT TECH
 
how to sell pi coins at high rate quickly.
how to sell pi coins at high rate quickly.how to sell pi coins at high rate quickly.
how to sell pi coins at high rate quickly.
DOT TECH
 
655264371-checkpoint-science-past-papers-april-2023.pdf
655264371-checkpoint-science-past-papers-april-2023.pdf655264371-checkpoint-science-past-papers-april-2023.pdf
655264371-checkpoint-science-past-papers-april-2023.pdf
morearsh02
 
The new type of smart, sustainable entrepreneurship and the next day | Europe...
The new type of smart, sustainable entrepreneurship and the next day | Europe...The new type of smart, sustainable entrepreneurship and the next day | Europe...
The new type of smart, sustainable entrepreneurship and the next day | Europe...
Antonis Zairis
 
Chương 6. Ancol - phenol - ether (1).pdf
Chương 6. Ancol - phenol - ether (1).pdfChương 6. Ancol - phenol - ether (1).pdf
Chương 6. Ancol - phenol - ether (1).pdf
va2132004
 
Commercial Bank Economic Capsule - May 2024
Commercial Bank Economic Capsule - May 2024Commercial Bank Economic Capsule - May 2024
Commercial Bank Economic Capsule - May 2024
Commercial Bank of Ceylon PLC
 
Intro_Economics_ GPresentation Week 4.pptx
Intro_Economics_ GPresentation Week 4.pptxIntro_Economics_ GPresentation Week 4.pptx
Intro_Economics_ GPresentation Week 4.pptx
shetivia
 

Recently uploaded (20)

Scope Of Macroeconomics introduction and basic theories
Scope Of Macroeconomics introduction and basic theoriesScope Of Macroeconomics introduction and basic theories
Scope Of Macroeconomics introduction and basic theories
 
how to sell pi coins on Bitmart crypto exchange
how to sell pi coins on Bitmart crypto exchangehow to sell pi coins on Bitmart crypto exchange
how to sell pi coins on Bitmart crypto exchange
 
What price will pi network be listed on exchanges
What price will pi network be listed on exchangesWhat price will pi network be listed on exchanges
What price will pi network be listed on exchanges
 
how to sell pi coins in South Korea profitably.
how to sell pi coins in South Korea profitably.how to sell pi coins in South Korea profitably.
how to sell pi coins in South Korea profitably.
 
what is the best method to sell pi coins in 2024
what is the best method to sell pi coins in 2024what is the best method to sell pi coins in 2024
what is the best method to sell pi coins in 2024
 
Empowering the Unbanked: The Vital Role of NBFCs in Promoting Financial Inclu...
Empowering the Unbanked: The Vital Role of NBFCs in Promoting Financial Inclu...Empowering the Unbanked: The Vital Role of NBFCs in Promoting Financial Inclu...
Empowering the Unbanked: The Vital Role of NBFCs in Promoting Financial Inclu...
 
where can I find a legit pi merchant online
where can I find a legit pi merchant onlinewhere can I find a legit pi merchant online
where can I find a legit pi merchant online
 
一比一原版BCU毕业证伯明翰城市大学毕业证成绩单如何办理
一比一原版BCU毕业证伯明翰城市大学毕业证成绩单如何办理一比一原版BCU毕业证伯明翰城市大学毕业证成绩单如何办理
一比一原版BCU毕业证伯明翰城市大学毕业证成绩单如何办理
 
Which Crypto to Buy Today for Short-Term in May-June 2024.pdf
Which Crypto to Buy Today for Short-Term in May-June 2024.pdfWhich Crypto to Buy Today for Short-Term in May-June 2024.pdf
Which Crypto to Buy Today for Short-Term in May-June 2024.pdf
 
Poonawalla Fincorp and IndusInd Bank Introduce New Co-Branded Credit Card
Poonawalla Fincorp and IndusInd Bank Introduce New Co-Branded Credit CardPoonawalla Fincorp and IndusInd Bank Introduce New Co-Branded Credit Card
Poonawalla Fincorp and IndusInd Bank Introduce New Co-Branded Credit Card
 
what is the future of Pi Network currency.
what is the future of Pi Network currency.what is the future of Pi Network currency.
what is the future of Pi Network currency.
 
Introduction to Indian Financial System ()
Introduction to Indian Financial System ()Introduction to Indian Financial System ()
Introduction to Indian Financial System ()
 
Exploring Abhay Bhutada’s Views After Poonawalla Fincorp’s Collaboration With...
Exploring Abhay Bhutada’s Views After Poonawalla Fincorp’s Collaboration With...Exploring Abhay Bhutada’s Views After Poonawalla Fincorp’s Collaboration With...
Exploring Abhay Bhutada’s Views After Poonawalla Fincorp’s Collaboration With...
 
how can I sell/buy bulk pi coins securely
how can I sell/buy bulk pi coins securelyhow can I sell/buy bulk pi coins securely
how can I sell/buy bulk pi coins securely
 
how to sell pi coins at high rate quickly.
how to sell pi coins at high rate quickly.how to sell pi coins at high rate quickly.
how to sell pi coins at high rate quickly.
 
655264371-checkpoint-science-past-papers-april-2023.pdf
655264371-checkpoint-science-past-papers-april-2023.pdf655264371-checkpoint-science-past-papers-april-2023.pdf
655264371-checkpoint-science-past-papers-april-2023.pdf
 
The new type of smart, sustainable entrepreneurship and the next day | Europe...
The new type of smart, sustainable entrepreneurship and the next day | Europe...The new type of smart, sustainable entrepreneurship and the next day | Europe...
The new type of smart, sustainable entrepreneurship and the next day | Europe...
 
Chương 6. Ancol - phenol - ether (1).pdf
Chương 6. Ancol - phenol - ether (1).pdfChương 6. Ancol - phenol - ether (1).pdf
Chương 6. Ancol - phenol - ether (1).pdf
 
Commercial Bank Economic Capsule - May 2024
Commercial Bank Economic Capsule - May 2024Commercial Bank Economic Capsule - May 2024
Commercial Bank Economic Capsule - May 2024
 
Intro_Economics_ GPresentation Week 4.pptx
Intro_Economics_ GPresentation Week 4.pptxIntro_Economics_ GPresentation Week 4.pptx
Intro_Economics_ GPresentation Week 4.pptx
 

Dynamic Fractionation in Radiotherapy

  • 1. Dynamic Optimization of a Linear-Quadratic Model with Incomplete Repair and Volume-Dependent Sensitivity and Repopulation Lawrence M. Wein Jonathan E. Cohen
  • 2. Abstract Purpose : The linear-quadratic model typically assumes that tumor sensitivity and repopulation are constant over the time course of radiotherapy. However, evidence suggests that the growth fraction increases and the cell loss factor decreases as the tumor shrinks. We investigate whether this evolution in tumor geometry , as well as the irregular time intervals between fractions in hyperfractionation schemes, can be exploited by fractionation schedules that employ time-varying fraction sizes .
  • 3. Methods: We construct a mathematical model of a spherical tumor with a hypoxic core and a viable rim , and embed this model into the traditional linear-quadratic model by assuming instantaneous reoxygenation. Dynamic programming is used to numerically compute the fractionation regimen that maximizes the tumor control probability (TCP) subject to constraints on the biologically effective dose of the early and late tissues.
  • 4. Results: In a numerical example that employs 10 fractions per week, optimally varying the fraction sizes increases the TCP from 0.7 to 0.966 , and the optimal regimen incorporates large Friday afternoon doses that are escalated throughout the course of treatment, and larger afternoon doses than morning doses. Conclusions: Numerical results suggest that a significant increase in tumor cure can be achieved by allowing the fraction sizes to vary throughout the course of treatment. Several strategies deserve further investigation: using larger fractions before overnight and weekend breaks , and escalating the dose (particularly on Friday afternoons) throughout the course of treatment.
  • 5. Linear Quadratic Model: Survival Curves plot the fraction of cells surviving radiation against the dose. This survival curve is best described by a linear quadratic model with the following formula: S = e -( α D + β D2) The α and β terms in this equation and the α / β ratio are used to describe survival curve characteristics and to classify cellular response to radiation.
  • 6. Tumor Control Probability Success or failure in controlling a tumor depends on killing the last surviving clonogen . Therefore, in terms of attempting permanent tumor control, if even one clonogen survives, the whole dose is wasted . A plot of control versus dose for a single tumor is therefore one of 0% response up to a certain dose and then an immediate increase to 100% response at the death of the last clonogen. However, the shape of the tumor control probability (TCP) curve for a series of patients , is different because cell killing is a random process. For example, if on an average 4 cars will cross a particular speed breaker in a road in one minute , what is the probability that no car will cross the point in a particular minute, or the probability that 1 car will cross the point. The answer to this question is given by the Poisson Distribution .
  • 7. Similarly, if a certain dose were to reduce the cell survival to an average of one clonogen per tumor , there would be, on average, among the series 37% with no survivors , 37% with one surviving clonogen, 18.4% with two surviving clonogens, 6.1% with three surviving clonogens, and 1.5% with four or more surviving clonogens. This 37% of tumors with no surviving clonogen will be declared cured, and the tumor control probability (TCP) is 37%. Poisson statistics correlate probability of tumor control with cell survival rate by the following formula: P=e -x where x is the average number of surviving clonogens per tumor, which in turn is the product of S.F. (fraction of cells surviving) and M (initial cell number).
  • 8. This study was stimulated by two perceived gaps in the LQ literature. The first gap is that the use of temporal optimization to exploit the irregular time intervals present in traditional non-accelerated protocols has yet to be studied. The second gap is the failure of the LQ model to capture the dynamics of reoxygenation and repopulation throughout the course of treatment. Evidence suggests that the evolution of tumor geometry during radiation treatment and its impact on radiosensitivity and repopulation can be exploited by time-varying fractionation regimens to further improve the therapeutic ratio. As a tumor shrinks during the course of therapy, diffusion-limited hypoxia decreases and necrotic regions become smaller and may eventually vanish.
  • 9.
  • 10. Tumor geometry . We consider a spherical tumor that consists of a hypoxic core and a viable rim . The tumor's size is defined by its radius R , which changes over time as a result of radiation killing, necrotic loss and repopulation. R If the current radius R is less than ro , (Oxygen Diffusion Distance) then the tumor contains no hypoxic core. R < ro R > ro If R > ro then the viable rim consists of the outer shell of thickness ro and the hypoxic core is the inner sphere of radius R - ro.
  • 11. Location-dependent sensitivity and repopulation. In our model, a cell's sensitivity ( α and β ) and its net repopulation rate ( γ ) depends upon its radial distance, r , from the center of the tumor, and on the current tumor radius, R. All three quantities, which will be defined by α (r, R), β (r, R) and γ (r, R), take on a fixed well-oxygenated level (denoted by α 0, β 0, γ 0 ) at the tumor surface (i.e., r = R) and decrease linearly as r decreases. α 0, β 0, γ 0 (r=R) 0,0,0 (r=R-ro)
  • 12. A tumor's overall sensitivity and repopulation rate. If f( α , β , γ ) is the joint probability density function of the three parameters for the various cells in a tumor of fixed size ,then the expected surviving fraction of cells after a dose of size d given over the infinitesimal interval of time The effective values of α , β , and γ are given by, respectively.
  • 13. The equivalent ODE . Suppose an arbitrary dose rate dt is applied over the time interval [0, T]. The surviving fraction of cells under the traditional (i.e., constant α and β and γ = 0 ) LQ model with incomplete repair (with repair rate μ ) is α D β D 2 To obtain an analogous result for volume-dependent sensitivity ( α t , β t ) and repopulation ( γ t ), we use the ODE model. Because the sensitivity and repopulation functions are expressed in terms of the radius, we need to express the differential equation in terms of the radius, not the number of cells.
  • 14. Problem formulation: The optimization problem is to choose a radiation schedule that maximizes the tumor control probability (TCP), subject to a constraint on the biologically effective dose (BED) of the early and late tissues . Mathematically, the problem is to choose T and {dt > 0, 0 < t < T} to maximize Subject to constraints
  • 15. Results: We restrict our numerical study to fractionation schemes that have 10 fractions per week. Time t = 0 corresponds to the first fraction given on Monday morning, there are two fractions per day that are separated by eight hours (each fraction's duration is one minute), and there is no treatment on the weekends. First, the initial tumor radius Ro is set equal to 0.5 cm , which corresponds to a typical tumor at the time of presentation. We set the viable rim radius ro equal to 0.05 cm , which is about three times larger than the oxygen diffusion limit in tumor tissue in order to reflect the fact that a tumor of this size would be vascularized. This value leads to 27.1% of the tumor being viable initially. The loss rate for necrotic debris is taken to be
  • 16. To assess the efficacy of the optimal solution, we compare it to the best static (i.e., fraction sizes do not vary over time) scheme, the hyperfractionation (HF) (70 fractions x 1.15 Gy) regimen and whose TCP is 0.7. The optimal solution to is displayed in Figure. This scheme administers a total of 66.81 Gy in six weeks , and achieves a TCP of 0.966 , which is a significant improvement over HF's TCP of 0.7. The resulting BED administered to the early and late tissues is 4.59 Gy and 98.5 Gy, respectively. Hence, the early constraint is binding under the optimal scheme but the late constraint has a slack of 13 Gy.
  • 17. The optimal solution in Figure possesses several interesting features. The most pronounced effect is the large doses on Friday afternoons . These large fractions are primarily used to compensate for the weekend breaks. However, a secondary factor could be that tumors are also smaller on Friday afternoon than at other times of the week, and smaller tumors are more sensitive and may attract larger fractions . There is also a significant am-pm effect : 60.0% of the total dose on Monday through Thursdays is administered in the afternoons . These large afternoon fractions offset the repopulation during the 16-hour gap until the next morning's fraction. A third feature of Figure is the intensification of the Friday afternoon doses throughout the course of treatment.
  • 18. Discussion: The foundation of the rationale for current fractionation schemes is the exploitation of the differences in radiation sensitivity and repopulation between the tumor and the normal (primarily late) tissue. Recent results show how the difference in repair rates can also be exploited by temporally optimizing the dose rate in accelerated protocols. The results in the present paper complement these ideas by suggesting that the therapeutic ratio can be further improved by exploiting two other factors : Irregular time intervals between doses caused by overnight and weekend breaks, and the changing radiosensitivity and repopulation rate of the tumor caused by reoxygenation.
  • 19. The weekend break was the most pronounced effect in our numerical example, causing Friday afternoon doses to be about 3.5 times larger than the other doses. The overnight effect was also significant, with afternoon doses accounting for 60.0% of the total dose administered on Mondays through Thursdays. The tumor increased its radiosensitivity and repopulation rates throughout the course of treatment , leading to 16.8% larger Friday afternoon doses in the latter three weeks of treatment than in the first three weeks of treatment. The optimal fractionation scheme compensates for irregular time intervals between doses by administering larger doses before longer breaks and shorter doses before shorter breaks .
  • 20. The optimal radiation policy exploits the reoxygenation process by taking into account the fact that as the tumor gets smaller , the tumor's sensitivity increases. Hence, giving large doses at the beginning of therapy is wasteful , since some of this dose can kill more cells if it is deferred until the tumor is smaller. Moreover, as the tumor shrinks, the growth fraction increases and the cell loss factor decreases, and consequently the repopulation rate increases . This provides an additional incentive to increase the dose rate (thereby reducing the length of treatment) when the tumor is smaller. In summary, an optimal radiation policy attempts to exercise patience when faced with a large tumor: it slowly and methodically chips away at the outer surface of the tumor, until the hypoxic core is sufficiently small, at which time the dose rate is increased until the end of treatment.
  • 21. Clinical Relevance: Dose intensification throughout the course of treatment can also be seen in concomitant boost (CB) therapy , where daily 1.8 Gy fractions are given for six weeks to the standard large field, plus an additional 1.5 Gy fraction is delivered to a reduced field on a daily basis for the last 10-12 days of treatment. The boost appears to be more efficacious when administered late in treatment rather than early, which is consistent with our results .
  • 22. Future Directions: Our results suggest that there is untapped potential for the use of dynamic fractionation schemes that incorporate the overnight effect, the weekend effect and the dose escalation effect . Our hope is that these types of models and analyses will provide a systematic way of generating and refining approaches to improve the therapeutic ratio of radiotherapy by temporal optimization of dose schedules.